Michael Hansen

Company: Janssen

Job title: Head of Biomarkers for Chronic Kidney Disease & Acute Kidney Injury

Seminars:

Panel Discussion: Pursuing the Next Gold Standard in Biomarker Development: Interrogating the Roadmap from Experimental to Validated 12:00 pm

• Developing molecular multi-marker panels to investigate how novel therapeutics interfere with disease processes and validating with longitudinal data • Proteomics, urinary transcriptomics, PROs and microRNA analysis: what correlates with clinical outcome and what is needed for validation? • How aggressively can we pursue surrogate endpoints?Read more

day: Track 2 - Day 1 AM